Skip Nav Destination
Issues
European Urology 1997, Vol. 31, No. 1
Clinical Paper
Human Androgen Receptor Expression in Prostate Cancer following Androgen Ablation
Subject Area:
Further Areas
Ralph de Vere White; Meyers Frederick; Sung-Gil Chi; Steven Chamberlain; Douglas Siders; Fred Lee; Susan Stewart; Paul H. Gumerlock
European Urology (1997) 31 (1): 1–6.
https://doi.org/10.1159/000474409
The Importance of Continued Endocrine Treatment during Chemotherapy of Hormone-Refractory Prostate Cancer
Subject Area:
Further Areas
European Urology (1997) 31 (1): 7–10.
https://doi.org/10.1159/000474410
Impact of Minimal Lymph Node Metastasis on Long-Term Prognosis after Radical Prostatectomy
Subject Area:
Further Areas
European Urology (1997) 31 (1): 11–16.
https://doi.org/10.1159/000474411
New Aspects of Urolithiasis in France
Subject Area:
Further Areas
European Urology (1997) 31 (1): 17–23.
https://doi.org/10.1159/000474412
Double Pigtail Ureteric Stent versus Percutaneous Nephrostomy: Effects on Stone Transit and Ureteric Motility
Subject Area:
Further Areas
European Urology (1997) 31 (1): 24–29.
https://doi.org/10.1159/000474413
The Value of Antibiotic Prophylaxis during Extracorporeal ShockWave Lithotripsy in the Prevention of Urinary Tract Infections in Patients with Urine Proven Sterile prior to Treatment
Subject Area:
Further Areas
A.F. Bierkens; A.J.M. Hendrikx; K. Ezz El Din; J.J.M.C.H. de la Rosette; A. Horrevorts; W. Doesburg; F.M.J. Debruyne
European Urology (1997) 31 (1): 30–35.
https://doi.org/10.1159/000474414
Transurethral Ureteroscopy:Is Local Anesthesia with Intravenous Sedation Sufficiently Effective and Safe?
Subject Area:
Further Areas
European Urology (1997) 31 (1): 36–39.
https://doi.org/10.1159/000474415
Radical Nephrectomy for Renal Cell Carcinoma:Long-Term Results and Prognostic Factors on a Series of 328 Cases
Subject Area:
Further Areas
European Urology (1997) 31 (1): 40–48.
https://doi.org/10.1159/000474416
Correlation between DNA Ploidy,Proliferation Marker Ki-67 and Early Tumor Progression in Renal Cell Carcinoma
Subject Area:
Further Areas
European Urology (1997) 31 (1): 49–53.
https://doi.org/10.1159/000474417
Evaluation of Urinary Glycosaminoglycan Excretion in Patients with Renal Cell Carcinoma
Subject Area:
Further Areas
Kemal Sarica; Kadir Türkölmez; Tarkan Soygür; Gökhan Özer; M. Önder Yaman; Sümer Baltaci; Yaşar Bedük; Y. Ziya Müftüoğlu
European Urology (1997) 31 (1): 54–57.
https://doi.org/10.1159/000474418
Pediatrie Urology
Treatment of Patients with Bladder Exstrophy or Incontinent Epispadias
Subject Area:
Further Areas
European Urology (1997) 31 (1): 58–64.
https://doi.org/10.1159/000474419
The Vanishing Testis: Anatomical and Histological Findings
Subject Area:
Further Areas
European Urology (1997) 31 (1): 65–67.
https://doi.org/10.1159/000474420
Bladder Rehabilitation, the Effect of a Cognitive Training Programme on Urge Incontinence
Subject Area:
Further Areas
European Urology (1997) 31 (1): 68–72.
https://doi.org/10.1159/000474421
Research Paper
Clinical Significance of Immunohistochemically Detectable p53 Protein in Renal Cell Carcinoma
Subject Area:
Further Areas
European Urology (1997) 31 (1): 73–80.
https://doi.org/10.1159/000474422
The 72nd Codon Change of p53 inPrimary Renal Cell Carcinoma WasConfirmed as a PolymorphismResearch Paper
The 72nd Codon Change of p53 in Primary Renal Cell Carcinoma Was Confirmed as a Polymorphism among Japanese
Subject Area:
Further Areas
European Urology (1997) 31 (1): 81–85.
https://doi.org/10.1159/000474423
Research Paper
A Flow Cytometric Analysis of the Expression of Adhesion Molecules on Human Renal Cell Carcinoma Cells with Different Metastatic Potentials
Subject Area:
Further Areas
European Urology (1997) 31 (1): 86–91.
https://doi.org/10.1159/000474424
Antitumor Effect of CPT-11,a Camptothecin Derivative,on Human Testicular Tumor Xenografts in Nude Mice
Subject Area:
Further Areas
Tsuneharu Miki; Masumi Sawada; Norio Nonomura; Yasauyuki Kojima; Akihiko Okuyama; Osamu Maeda; Shigeru Saiki; Toshihiko Kotake
European Urology (1997) 31 (1): 92–96.
https://doi.org/10.1159/000474425
Enzyme Activities in Tissue of Human Benign Prostatic Hyperplasia after Three Months' Treatment with the Sabalserrulata Extract IDS 89(Strogen®) or Placebo
Subject Area:
Further Areas
European Urology (1997) 31 (1): 97–101.
https://doi.org/10.1159/000474426
Intussuscepted Partial-Thickness Ileal Valve in Continent Urinary Diversion
Subject Area:
Further Areas
European Urology (1997) 31 (1): 102–107.
https://doi.org/10.1159/000474427
Ultrastructural Mucosal Appearance in the Ileal Neobladder
Subject Area:
Further Areas
European Urology (1997) 31 (1): 108–111.
https://doi.org/10.1159/000474428
Case Report
Arteriovenous Fistula following Nephrectomy
Subject Area:
Further Areas
European Urology (1997) 31 (1): 112–114.
https://doi.org/10.1159/000474429
Treatment of Dual Urinary and Fecal Incontinence by Implantation of Two AMS 800 Artificial Sphincters
Subject Area:
Further Areas
A. Gelet; P. Meunier; R. Lombard Platet; A.F. AbdelRahim; S. Friaa; J.G. Lopez; K. Manzan; J.M. Dubernard
European Urology (1997) 31 (1): 115–118.
https://doi.org/10.1159/000474430
Direct Invasion of the Renal Vein by Metastatic Testicular Cancer
Subject Area:
Further Areas
European Urology (1997) 31 (1): 119–121.
https://doi.org/10.1159/000474431
Malignant Pheochromocytoma of the Bladder: Current Controversies
Subject Area:
Further Areas
European Urology (1997) 31 (1): 122–125.
https://doi.org/10.1159/000474432
Letter to the Editor
The Treatment of Vesicovaginal Fistulae
Subject Area:
Further Areas
European Urology (1997) 31 (1): 126.
https://doi.org/10.1159/000474433
Longitudinal Evaluation of Prostate-Specific Antigen Levels in a Case-Control Study
Subject Area:
Further Areas
European Urology (1997) 31 (1): 127.
https://doi.org/10.1159/000474434
Reply
Subject Area:
Further Areas
European Urology (1997) 31 (1): 128.
https://doi.org/10.1159/000474435
